| Literature DB >> 33072183 |
Sajad Mansouri1, Amir Jalali2, Mahmoud Rahmati1, Nader Salari3.
Abstract
BACKGROUND: In addition to physical, mental, and social condition, ESRD and hemodialysis affect the quality of life of patients as well. Psychotherapy and non-pharmaceutical interventions are effective measures to add meaning to life, create a goal and motivation in life, and improve the quality of life in chronic patients. The effect of educational and supportive group therapy on the quality of life (QOL) of hemodialysis patients was examined.Entities:
Keywords: ESRD; Group therapy; Quality of life
Year: 2020 PMID: 33072183 PMCID: PMC7560021 DOI: 10.1186/s13030-020-00200-z
Source DB: PubMed Journal: Biopsychosoc Med ISSN: 1751-0759
Fig. 1Study flow chart
KDQOL-SFTM and the subscales
| KDQOL-SF™ | Number of Items | Cronbach ‘s Alpha |
|---|---|---|
| Symptom/Problem list(S/PL) | ||
| Effects of kidney disease (EKD) | ||
| Burden of kidney disease (BKD) | ||
| Work Status (WS) | ||
| Cognitive function (CF) | ||
| Quality of social interaction (QSI) | ||
| Sexual function (SexF) | ||
| Sleep (S) | ||
| Social support (SS) | ||
| Dialysis staff encouragement (DSE) | ||
| Patient satisfaction (PS) | ||
| Physical functioning (PF) | ||
| Role-Physical limitation (RPL) | ||
| Pain | ||
| General health (GH) | ||
| Emotional well-being (EW) | ||
| Role-emotional limitation (REL) | ||
| Social function (SocF) | ||
| Energy/fatigue (E/F) | ||
Demographic characteristics
| Variables | Experimental N (%) | Control N (%) | ||
|---|---|---|---|---|
| Agea | Less than 35 Y | 1 (3.3) | 1 (3.3) | 0.317 |
| 35–55 Y | 22 (73.3) | 18 (60) | ||
| More than 55 Y | 7 (23.3) | 11 (36.7) | ||
| Sexa | Female | 3 (10) | 4 (13.3) | 0.69 |
| Male | 27 (90) | 26 (86.7) | ||
| Marital status | Unmarried | 29 (96.7) | 28 (93.3) | 0.557 |
| Married | 1 (3.3) | 2 (6.6) | ||
| Education | Elementary | 21 (70) | 25 (83.3) | 0.301 |
| High school | 6 (20) | 3 (10) | ||
| Higher education | 3 (10) | 2 (6.7) | ||
| Job | Employed | 4 (13.3) | 6 (20) | |
| Unemployed | 23 (76.6) | 21 (70) | ||
| Housewife | 3 (10) | 3 (10) | ||
| Monthly Income | Less than 800$ | 26 (86.7) | 24 (80) | 0.317 |
| 800–1200$ | 1 (3.3) | 5 (16.7) | ||
| More than 1200$ | 3 (10) | 1 (3.3) | ||
| Hemodialysis History | Less than 1 Y | 4 (13.3) | 4 (13.3) | 0.92 |
| 1–3 Y | 13 (43.3) | 17 (56.7) | ||
| More than 3Y | 13 (43.3) | 9 (30) | ||
| Domicile | Urban | 25 (83.3) | 26 (86.7) | 0.72 |
| Rural area | 5 (16.7) | 4 (13.3) | ||
aYates correction test
Fig. 2The trend of changes in the mean scores of ESRD-targeted areas in the three stages (before, immediately after and follow-up) in the two groups
Fig. 3The trend of changes in the mean scores of Health survey in the three stages (before, immediately after and follow-up) in the two groups
Fig. 4The trend of changes in the mean scores of KDQOL in the three stages (before, immediately after and follow-up) in the two groups
Mean scores of KDQOL, ESRD-targeted area, and Health
| Time | Mean ± SD | T | |||
|---|---|---|---|---|---|
| Control | Experimental | ||||
| ESRD-targeted area | Pre | 38.57 ± 4.66 | 39.39 ± 3.9 | −0.652 | 0.517 |
| Post | 39.72 ± 4.27 | 46.32 ± 4.52 | −5.72 | 0.0001 | |
| Follow up | 39.25 ± 4.32 | 47.57 ± 4.4 | −7.02 | 0.0001 | |
| Health survey | Pre | 33.39 ± 4.92 | 33.84 ± 3.96 | −0.388 | 0.699 |
| Post | 33.75 ± 5.36 | 39. 14 ± 2.95 | −4.82 | 0.0001 | |
| Follow up | 34.14 ± 5.13 | 41.25 ± 4.13 | −5.91 | 0.0001 | |
| KDQOL | Pre | 36.39 ± 3.88 | 36.99 ± 2.65 | −0.708 | 0.482 |
| Post | 37.2 ± 4.03 | 43.3 ± 2.87 | −6.74 | 0.0001 | |
| Follow up | 37.1 ± 4.08 | 44.9 ± 3.47 | −7.97 | 0.0001 | |
Mean sub-scales scores of KDQOL
| Mean ± SD | |||||
|---|---|---|---|---|---|
| Group | Pre | Post | Follow up | ||
| Symptom/Problem list(S/PL) | Control | 40.08 ± 7.84 | 40.67 ± 10.48 | 41.33 ± 11.14 | 0.819 |
| Experimental | 39.85 ± 7.57 | 46.83 ± 14.31 | 47.62 ± 14.86 | 0.031 | |
| 0.798 | 0.118 | 0.122 | |||
| Effects of kidney disease (EKD) | Control | 29.27 ± 9.62 | 29.27 ± 9.27 | 28.85 ± 9.67 | 0.549 |
| Experimental | 31.3 ± 6.41 | 40.41 ± 12.38 | 41.77 ± 11. 6 | 0.0001 | |
| 0.34 | 0.0001 | 0.0001 | |||
| Burden of kidney disease (BKD) | Control | 32.71 ± 14.92 | 34.58 ± 14.93 | 33.96 ± 16.06 | 0.247 |
| Experimental | 35.83 ± 10.12 | 41.95 ± 10.41 | 43.23 ± 10.59 | 0.012 | |
| 0.405 | 0.124 | 0.708 | |||
| Work Status (WS) | Control | 18.33 ± 21.71 | 22.5 ± 22.12 | 22.5 ± 23.07 | 0.016 |
| Experimental | 18.33 ± 15.99 | 25 ± 18.57 | 25 ± 17.37 | 0.066 | |
| 0.749 | 0.605 | 0.588 | |||
| Cognitive function (CF) | Control | 45.55 ± 16.16 | 49.55 ± 16.32 | 47.8 ± 15.16 | 0.006 |
| Experimental | 46.03 ± 10.72 | 56.45 ± 8.01 | 56.13 ± 8.28 | 0.0001 | |
| 0.952 | 0.137 | 0.026 | |||
| Quality of social interaction (QSI) | Control | 60.44 ± 18.69 | 59.77 ± 19.85 | 57.33 ± 19.62 | 0.368 |
| Experimental | 60.54 ± 17.75 | 63.43 ± 15.62 | 61.04 ± 17.76 | 0.64 | |
| 0.782 | 0.81 | 0.77 | |||
| Sexual function (SexF) | Control | 41 ± 11.25 | 40.83 ± 10.99 | 40.83 ± 10.99 | 0.368 |
| Experimental | 40.42 ± 6.2 | 44.08 ± 7.58 | 44.5 ± 6.1 | 0.0001 | |
| 0.643 | 0.066 | 0.046 | |||
| Sleep (S) | Control | 49.17 ± 14.15 | 50 ± 13.34 | 47.83 ± 15.63 | 0.016 |
| Experimental | 47.13 ± 12.43 | 53.67 ± 12.65 | 59.13 ± 12.56 | 0.0001 | |
| 0.051 | 0.056 | 0.004 | |||
| Social support (SS) | Control | 30.72 ± 12.8 | 31 ± 11.4 | 31.72 ± 12.27 | 0.488 |
| Experimental | 31.19 ± 6.42 | 36.88 ± 6.29 | 39.91 ± 7.6 | 0.0001 | |
| 0.546 | 0.005 | 0.003 | |||
| Dialysis staff encouragement (DSE) | Control | 37.96 ± 8.93 | 40.31 ± 9.5 | 41.14 ± 9.09 | 0.018 |
| Experimental | 40.37 ± 11.07 | 45.93 ± 8.13 | 48.56 ± 6.94 | 0.0001 | |
| 0.881 | 0.003 | 0.0001 | |||
| Patient satisfaction (PS) | Control | 39 ± 22.07 | 41 ± 13.48 | 39.17 ± 10.35 | 0.379 |
| Experimental | 41.21 ± 17.08 | 54.87 ± 17.08 | 56.09 ± 18.82 | 0.0001 | |
| 0.453 | 0.002 | 0.0001 | |||
| Physical functioning (PF) | Control | 38.17 ± 10.46 | 37.67 ± 11.65 | 36.5 ± 10.18 | 0.247 |
| Experimental | 39.5 ± 11.09 | 41.67 ± 10.69 | 43.81 ± 9.71 | 0.003 | |
| 0.317 | 0.029 | 0.003 | |||
| Role-Physical limitation (RPL) | Control | 21.67 ± 25.2 | 23.33 ± 25.37 | 21.67 ± 25.2 | 0.368 |
| Experiment | 20.83 ± 13.27 | 29.17 ± 11.53 | 31.67 ± 18.49 | 0.014 | |
| 0.543 | 0.085 | 0.04 | |||
| Pain (P) | Control | 31.66 ± 10.24 | 30.42 ± 10.21 | 31.75 ± 10.57 | 0.867 |
| Experimental | 31.75 ± 9.76 | 36.33 ± 9.3 | 35.75 ± 9.19 | 0.006 | |
| 0.782 | 0.033 | 0.154 | |||
| General health (GH) | Control | 39 ± 12.06 | 37.67 ± 12.44 | 37.5 ± 12.3 | 0.368 |
| Experimental | 42.61 ± 7.12 | 46.19 ± 4.27 | 51.69 ± 5.12 | 0.0001 | |
| 0.635 | 0.041 | 0.0001 | |||
| Emotional well-being (EW) | Control | 40.4 ± 19.05 | 42.17 ± 19.76 | 43.8 ± 21.05 | 0.004 |
| Experimental | 38.87 ± 5.82 | 47.33 ± 3.94 | 49.15 ± 6.33 | 0.0001 | |
| 0.995 | 0.282 | 0.35 | |||
| Role-emotional limitation (REL) | Control | 21.10 ± 18.53 | 22.22 ± 23.7 | 21.22 ± 22.19 | 0.931 |
| Experimental | 22.22 ± 15.98 | 23.33 ± 17.83 | 25.55 ± 14.34 | 0.81 | |
| 0.724 | 0.643 | 0.306 | |||
| Social function (SocF) | Control | 38.6 ± 4.63 | 39.66 ± 4.35 | 42.81 ± 6.08 | 0.007 |
| Experimental | 37.55 ± 5.21 | 43.38 ± 9.51 | 47.54 ± 8.67 | 0.0001 | |
| 0.089 | 0.003 | 0.006 | |||
| Energy/fatigue (E/F) | Control | 36.53 ± 9.1 | 39.87 ± 7.94 | 37.87 ± 9.47 | 0.521 |
| Experimental | 38.4 ± 8.81 | 45.73 ± 9.88 | 44.83 ± 10.10 | 0.0001 | |
| 0.509 | 0.0001 | 0.007 | |||
* U-Mann-Whitney test **Friedman test